Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples